AKT1 and gastric cancer: Moreover, Zhu et al. found that tRF-5026a (tRF-18-79MP9P04) inhibits GC cell proliferation, migration, and cell cycle progression through PTEN/PI3K/AKT signaling, and is a promising diagnostic biomarker for GC [129] (Fig. 2c).